Gut Microbes From Older Mice Boosted Fertility in Younger Ones - the Opposite of What Scientists Expected

The experiment was designed to confirm a straightforward hypothesis: expose young, healthy ovaries to an aged gut microbiome, and the ovaries will decline. Older gut bacteria would presumably carry signs of metabolic wear, reduced microbial diversity, and inflammatory signals that would accelerate reproductive aging in younger animals.

The results went the other direction entirely.

Young female mice that received gut microbiome transplants from older, post-reproductive donors showed rejuvenated ovarian gene expression, substantially reduced inflammatory markers, and better reproductive outcomes than mice that received transplants from young donors. The work, published in Nature Aging by a team at the USC Leonard Davis School of Gerontology, suggests the relationship between gut bacteria and reproductive aging is more dynamic - and less predictable - than researchers had assumed.

Remodeling the Microbiome

The study, led by senior author Berenice Benayoun, associate professor at USC Leonard Davis, and first author Min Hoo Kim, a postdoctoral researcher, used a specific experimental design to isolate the microbiome's effects. Young adult female mice first received antibiotics to clear their existing gut bacteria, then received fecal transplants from either other young mice or from estropausal donors - older mice in a post-reproductive state analogous to human menopause.

After the transplants took hold, the researchers examined several measures of ovarian health. The transcriptomes of ovarian cells - the full range of messenger RNA produced during protein synthesis - in mice that received older microbiome transplants resembled those of much younger animals. Inflammation markers in ovarian tissue were substantially reduced compared to mice that received young microbiome transplants. And when the transplanted mice were paired with males, the results were striking: all mice that received the older microbiome produced pups, while some mice that received the younger microbiome produced none at all.

"Our original hypothesis was that we would see damaging effects of the older microbiome on ovarian function, but surprisingly, we found the opposite," Kim said.

The Estrobolome Hypothesis

Why would an aged microbiome rejuvenate rather than damage younger ovaries? Benayoun and her coauthors propose a mechanism involving the estrobolome - a subset of gut bacteria involved in estrogen metabolism. These microbes work in tandem with signals from the reproductive system to maintain hormone balance.

As ovaries age, they respond less vigorously to hormonal signals from gut bacteria. To compensate, the bacteria involved in estrogen metabolism may upregulate their signaling. When that highly activated older microbiome is transplanted into a younger animal with ovaries still fully responsive to those signals, the result may be an overstimulation that produces an apparent rejuvenation effect.

The hypothesis fits the data, but the researchers are clear that it remains a hypothesis at this stage. The study is conducted in mice, and the translation to human biology requires significant additional validation. The paper identifies specific bacterial species and related metabolic pathways as candidates for future investigation, but the precise mechanistic chain from gut bacteria to ovarian gene expression has not been fully mapped.

Ovarian Aging and Broader Health

The significance of ovarian aging extends beyond reproductive function. Earlier menopause has been linked to shorter lifespan, and the hormonal changes associated with menopause substantially increase risks for osteoporosis, cardiovascular disease, and dementia. Any approach that could modulate the pace of ovarian aging would therefore have implications well beyond fertility.

"Menopause isn't just about no longer being fertile," Benayoun said. "It has dramatic negative effects on women's overall health and is associated with huge increases in risks of diseases ranging from osteoporosis and diabetes to heart disease and dementia. If we could effectively delay menopause, it would help women live longer, healthier lives."

The findings add to a growing body of evidence connecting gut microbial communities to health outcomes across multiple organ systems, including brain function, cardiovascular health, and metabolism. The ovary-microbiome axis has been among the least studied of these connections.

The critical limitation here is the animal model. Effects observed in mice following antibiotic-induced microbiome clearance and subsequent transplantation may not replicate in humans, where gut ecosystems are far more complex, continuous exposure to dietary and environmental factors shapes the microbiome differently, and the hormonal landscape differs substantially from rodents. The researchers note that targeted manipulation of specific bacterial populations - rather than whole-microbiome transplantation - is likely the more clinically tractable path forward, and identifying exactly which species and metabolites drive the observed effects is a central goal for follow-up work.